IL17A and tuberculosis: IL-17 and TGF-β plasma levels were increased among PTB patients only at the beginning of anti-TB treatment (T1) and plasma levels for TNF-α were lower among PTB patients during anti-TB treatment (T1, T2, and T3) (data not shown).